Marcel van der Brug

Company: AcuraStem Inc.

Job title: Chief Scientific Officer

Seminars:

Embracing Heterogeneity in ALS to Develop Diverse In Vitro Models that can Support Development of Targeted Therapeutics 11:10 am

•  ALS patients present with significant heterogeneity in disease features, that may share related, common mechanisms • Most ALS disease models focus on rare forms of the disease and are not genetically representative of >80% of patients with sporadic ALS • Developing and selecting drug candidates in diverse patient cell lines is standard practice in…Read more

day: Conference Day One Track A